Glycomine

Provider of replacement therapies for rare genetic diseases

placeSan Francisco, California, United States calendar_todayFounded 2015 groups20 employees language glycomine.com

Innovation

5 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 223 times.

YearFilings
20151
20161
20171
20181
20191
20202
20212
20222
20233
20242
20255
20262

Social engagement

Social engagement: 3.9K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Abingworth, Sanofi Ventures, Sanderling Ventures, Novo Holdings.

Investor typeCountShare
Venture capital1372%
Accelerator & incubator16%
Other / undisclosed422%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

27 Jun 2025 · Medical Director / Senior Medical Director, Medical Affairs (Remote) · Boston

22 Jun 2025 · Medical Director/Senior Medical Director, Medical Affairs (Remote) · Charlotte

Based on job postings tracked across public sources.

Recent activity

3 Sep 2025
Milestone
regulatory
Coming soon